Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

An Insider Likes The New Freeport-McMoRan Copper & Gold Inc. (FCX)

Page 1 of 2

Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX) recently completed its purchase of oil and gas companies McMoRan Exploration (which had previously been a related company) and Plains Exploration and Production. The company’s stock price plunged in early December when it announced the acquisitions, and is still down 22% from the beginning of that month as markets have worried that the diversification into oil and gas will reduce Freeport-McMoRan’s focus (in addition to a belief that the company overpaid for these acquisitions).

Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX)

Now a Form 4 filed with the SEC has disclosed that vice chairman of the Board James Flores purchased 1.1 million shares of the stock through a variety of affiliated limited partnerships on June 3rd at prices generally ranging from $31 to $31.50 per share. These LPs now own roughly 1.8 million shares of the stock, in addition to over 4 million shares held by Flores directly. As such, this buying activity increases his company-specific risk, while economic theory holds that it is generally rational for an insider to diversify their wealth away from the company unless they are particularly confident in its prospects. This is one explanation for why stocks bought by insiders tend to narrowly outperform the market (read our analysis of studies on insider trading).

Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX) is generally seen as an indicator of broader economic activity (due to the dependence of copper demand on macro factors). The stock’s beta is 2.4, reflecting this. While the stock would certainly be a poor defensive pick, its quarterly dividend payments of 31.3 cents per share imply an annual yield of 4% at current prices- potentially making it quite appealing to income investors, though of course there would still be commodity and integration risks. Wall Street analysts project $4.07 in earnings per share next year, implying a forward P/E of 8.

In addition to insider trading activity, we also track quarterly 13Fs from hedge funds as part of our work developing investment strategies (we have found, for example, that the most popular small cap stocks among hedge funds earn an average excess return of 18 percentage points per year). We can see from our database of filings that billionaire John Paulson’s Paulson & Co. owned 9 million shares of Freeport-McMoRan at the end of March (see Paulson’s stock picks).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!